Invention Grant
- Patent Title: Compounds and compositions for inhibition of FASN
-
Application No.: US16119962Application Date: 2018-08-31
-
Publication No.: US10399951B2Publication Date: 2019-09-03
- Inventor: Kenneth W. Bair , David R. Lancia, Jr. , Hongbin Li , James Loch , Wei Lu , Matthew W. Martin , David S. Millan , Shawn E. R. Schiller , Mark J. Tebbe
- Applicant: FORMA Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: FORMA THERAPEUTICS, INC.
- Current Assignee: FORMA THERAPEUTICS, INC.
- Current Assignee Address: US MA Watertown
- Agency: Brinks Gilson & Lione
- Main IPC: C07D295/192
- IPC: C07D295/192 ; A61K31/4965 ; A61P35/00 ; C07D401/04 ; C07D403/04 ; C07D405/12 ; C07D413/12 ; C07D417/04 ; C07D417/12 ; C07D471/04 ; C07D491/048 ; C07D495/04 ; C07D213/65 ; C07D213/69 ; C07D213/56 ; C07D231/12 ; C07D235/08 ; C07D209/08 ; C07D209/18 ; C07D263/57 ; C07D271/12 ; C07D277/66 ; C07D277/62 ; C07D513/04 ; A61K31/495 ; A61K31/496 ; A61K31/497 ; A61K31/4985 ; A61K45/06 ; C07D215/14 ; C07D231/56 ; C07D257/04 ; C07D487/04 ; C07D305/08 ; A61K31/5025 ; A61K31/506 ; C07D217/16
Abstract:
The present invention relates to compounds and compositions for inhibition of FASN, their synthesis, applications, and antidotes.
Public/Granted literature
- US20180370933A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN Public/Granted day:2018-12-27
Information query
